152 related articles for article (PubMed ID: 34461485)
1. A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care.
Shimozaki K; Nakayama I; Takahari D; Kamiimabeppu D; Osumi H; Wakatsuki T; Ooki A; Ogura M; Shinozaki E; Chin K; Yamaguchi K
ESMO Open; 2021 Oct; 6(5):100234. PubMed ID: 34461485
[TBL] [Abstract][Full Text] [Related]
2. Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials.
Takahari D; Mizusawa J; Koizumi W; Hyodo I; Boku N
Gastric Cancer; 2017 Sep; 20(5):757-763. PubMed ID: 28205060
[TBL] [Abstract][Full Text] [Related]
3. Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.
Takahari D; Boku N; Mizusawa J; Takashima A; Yamada Y; Yoshino T; Yamazaki K; Koizumi W; Fukase K; Yamaguchi K; Goto M; Nishina T; Tamura T; Tsuji A; Ohtsu A
Oncologist; 2014 Apr; 19(4):358-66. PubMed ID: 24668328
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
5. Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutions.
Yamamoto S; Kanzaki H; Sakaguchi C; Mouri H; Tsuzuki T; Nasu J; Kobayashi S; Toyokawa T; Obayashi Y; Inoue M; Kato R; Matsubara M; Kita M; Okada H
Jpn J Clin Oncol; 2023 Oct; 53(10):928-935. PubMed ID: 37519053
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.
Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Tamura T; Yatabe T; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Gastric Cancer; 2019 Jul; 22(4):684-691. PubMed ID: 30417313
[TBL] [Abstract][Full Text] [Related]
8. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ
J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
[TBL] [Abstract][Full Text] [Related]
10. Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting.
Nakayama I; Takahari D; Wakatsuki T; Osumi H; Chin K; Ogura M; Sato T; Suzuki T; Kamiimabeppu D; Ooki A; Suenaga M; Shinozaki E; Yamaguchi K
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32273288
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.
Fuchs CS; Muro K; Tomasek J; Van Cutsem E; Cho JY; Oh SC; Safran H; Bodoky G; Chau I; Shimada Y; Al-Batran SE; Passalacqua R; Ohtsu A; Emig M; Ferry D; Chandrawansa K; Hsu Y; Sashegyi A; Liepa AM; Wilke H
J Gastric Cancer; 2017 Jun; 17(2):132-144. PubMed ID: 28680718
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy.
Wang J; Qu J; Li Z; Che X; Zhang J; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
Transl Oncol; 2016 Jun; 9(3):256-61. PubMed ID: 27267846
[TBL] [Abstract][Full Text] [Related]
16. New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy.
Koo DH; Ryu MH; Lee MY; Moon MS; Kang YK
World J Gastroenterol; 2021 Dec; 27(48):8357-8369. PubMed ID: 35068874
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer.
Shim HJ; Yun JY; Hwang JE; Bae WK; Cho SH; Chung IJ
Gastric Cancer; 2011 Aug; 14(3):249-56. PubMed ID: 21431297
[TBL] [Abstract][Full Text] [Related]
18. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
[No Abstract] [Full Text] [Related]
19. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.
Kadowaki S; Komori A; Narita Y; Nitta S; Yamaguchi K; Kondo C; Taniguchi H; Takahari D; Ura T; Ando M; Muro K
Int J Clin Oncol; 2014 Aug; 19(4):656-61. PubMed ID: 23999902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
